Stay updated on Phase 2 DaxibotulinumtoxinA Clinical Trial

Sign up to get notified when there's something new on the Phase 2 DaxibotulinumtoxinA Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Phase 2 DaxibotulinumtoxinA Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov site revision label changed from v3.8.0 to v3.8.1.
    Difference
    0.1%
    Check dated 2026-11-18T01:16:03.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The clinical trial record for a Phase 2 study of daxibotulinumtoxinA for plantar fasciitis is displayed, including its study plan, participant criteria, locations, and outcome measures.
    Difference
    48%
    Check dated 2026-11-10T20:15:32.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The footer revision changed from v3.7.2 to v3.8.0. The page continues to display a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-11-03T21:20:04.000Z thumbnail image
  4. Check
    32 days ago
    Change Detected
    Summary
    A general NIH announcement about terminology during the agency transition appears above the page, and the site revision changes from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-20T20:53:14.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.0 to v3.7.1; the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-06T20:27:05.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    Removed the 403 error page wrapper and the Home link, indicating the error UI was removed or bypassed. The change affects navigation/placeholder UI but does not alter the study details content.
    Difference
    0.5%
    Check dated 2026-09-29T20:29:02.000Z thumbnail image

Stay in the know with updates to Phase 2 DaxibotulinumtoxinA Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Phase 2 DaxibotulinumtoxinA Clinical Trial page.